Published in Circulation on September 02, 1997
Vitamin D and human health: lessons from vitamin D receptor null mice. Endocr Rev (2008) 5.28
Vitamin D for health: a global perspective. Mayo Clin Proc (2013) 2.41
Genetic ancestry is associated with subclinical cardiovascular disease in African-Americans and Hispanics from the multi-ethnic study of atherosclerosis. Circ Cardiovasc Genet (2009) 2.31
Association of the vitamin D metabolism gene CYP24A1 with coronary artery calcification. Arterioscler Thromb Vasc Biol (2010) 1.69
Hypovitaminosis D in chronic kidney disease. Clin J Am Soc Nephrol (2008) 1.50
Vitamin D receptor activators can protect against vascular calcification. J Am Soc Nephrol (2008) 1.35
Serum vitamin D, parathyroid hormone levels, and carotid atherosclerosis. Atherosclerosis (2009) 1.21
Potential for vitamin D receptor agonists in the treatment of cardiovascular disease. Br J Pharmacol (2009) 1.13
CYP24A1 and CYP27B1 polymorphisms modulate vitamin D metabolism in colon cancer cells. Cancer Res (2013) 1.08
25-Hydroxyvitamin D deficiency is associated with increased aortic stiffness in patients with systemic lupus erythematosus. Rheumatology (Oxford) (2011) 1.02
Racial differences in the burden of coronary artery calcium and carotid intima media thickness between Blacks and Whites. Neth Heart J (2015) 0.97
Vitamin D and osteogenic differentiation in the artery wall. Clin J Am Soc Nephrol (2008) 0.92
Trace elements, heavy metals and vitamin levels in patients with coronary artery disease. Int J Med Sci (2011) 0.89
Vitamin D receptor activators induce an anticalcific paracrine program in macrophages: requirement of osteopontin. Arterioscler Thromb Vasc Biol (2009) 0.89
Ethnic differences in aortic valve thickness and related clinical factors. Am Heart J (2010) 0.89
The immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability? Clin Dev Immunol (2007) 0.87
The prevalence and distribution of coronary artery calcium in asymptomatic Korean population. Int J Cardiovasc Imaging (2011) 0.86
Symptom expression in coronary heart disease and revascularization recommendations for black and white patients. Am J Public Health (2007) 0.85
Vitamin D deficiency does not predict progression of coronary artery calcium, carotid intima-media thickness or high-sensitivity C-reactive protein in systemic lupus erythematosus. Rheumatology (Oxford) (2013) 0.84
High levels of serum vitamin D are associated with a decreased risk of metabolic diseases in both men and women, but an increased risk for coronary artery calcification in Korean men. Cardiovasc Diabetol (2016) 0.81
Progression of coronary atherosclerosis in African-American patients. Cardiovasc Diagn Ther (2013) 0.79
Active vitamin D and accelerated progression of aortic stiffness in hemodialysis patients: a longitudinal observational study. Am J Hypertens (2014) 0.78
Associations between a parental history of premature cardiovascular disease and coronary artery calcium and carotid intima-media thickness: the Coronary Artery Risk Development In Young Adults (CARDIA) study. Eur J Prev Cardiol (2012) 0.77
Genetic ancestry is associated with measures of subclinical atherosclerosis in African Americans: the Jackson Heart Study. Arterioscler Thromb Vasc Biol (2015) 0.76
Racial disparities in outcomes following coronary artery bypass grafting. J Cardiovasc Nurs (2006) 0.76
Baseline vitamin D deficiency decreases the effectiveness of statins in HIV-infected adults on antiretroviral therapy. J Acquir Immune Defic Syndr (2016) 0.75
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): II. Clinical efficacy and pharmacokinetics in relapsed patients. Blood (1997) 4.78
Bone morphogenetic protein expression in human atherosclerotic lesions. J Clin Invest (1993) 4.54
Atherosclerosis: basic mechanisms. Oxidation, inflammation, and genetics. Circulation (1995) 3.82
Use of arsenic trioxide (As2O3) in the treatment of acute promyelocytic leukemia (APL): I. As2O3 exerts dose-dependent dual effects on APL cells. Blood (1997) 3.56
Coronary calcium does not accurately predict near-term future coronary events in high-risk adults. Circulation (1999) 2.80
Lipid oxidation products have opposite effects on calcifying vascular cell and bone cell differentiation. A possible explanation for the paradox of arterial calcification in osteoporotic patients. Arterioscler Thromb Vasc Biol (1997) 2.80
Oxidative stress modulates osteoblastic differentiation of vascular and bone cells. Free Radic Biol Med (2001) 2.79
Indirubin, the active constituent of a Chinese antileukaemia medicine, inhibits cyclin-dependent kinases. Nat Cell Biol (1999) 2.78
The Yin and Yang of oxidation in the development of the fatty streak. A review based on the 1994 George Lyman Duff Memorial Lecture. Arterioscler Thromb Vasc Biol (1996) 2.56
Sublingual capnometry: a new noninvasive measurement for diagnosis and quantitation of severity of circulatory shock. Crit Care Med (1999) 2.54
TGF-beta 1 and 25-hydroxycholesterol stimulate osteoblast-like vascular cells to calcify. J Clin Invest (1994) 2.43
Apoptosis and growth inhibition in malignant lymphocytes after treatment with arsenic trioxide at clinically achievable concentrations. J Natl Cancer Inst (1999) 2.41
Active serum vitamin D levels are inversely correlated with coronary calcification. Circulation (1997) 2.32
Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determination of arterial calcification. Arterioscler Thromb (1994) 2.31
A natural BH3 mimetic induces autophagy in apoptosis-resistant prostate cancer via modulating Bcl-2-Beclin1 interaction at endoplasmic reticulum. Cell Death Differ (2010) 2.25
The dynamics of progression of coronary atherosclerosis studied in 168 medically treated patients who underwent coronary arteriography three times. Am Heart J (1989) 2.25
Electron beam computed tomographic coronary calcium as a predictor of coronary events: comparison of two protocols. Circulation (1997) 2.24
Tumor necrosis factor-alpha promotes in vitro calcification of vascular cells via the cAMP pathway. Circulation (2000) 2.22
Exercise testing and electron beam computed tomography in the evaluation of coronary artery disease. J Am Coll Cardiol (2000) 2.15
Gastric intramural PCO2 during peritonitis and shock. Chest (1993) 2.13
Racial differences in the significance of coronary calcium in asymptomatic black and white subjects with coronary risk factors. J Am Coll Cardiol (1999) 1.97
Airway protection during experimental CPR. Chest (1995) 1.96
Coronary artery calcium evaluation by electron beam computed tomography and its relation to new cardiovascular events. Am J Cardiol (2000) 1.92
Odontogenic tumours: a retrospective study of 1642 cases in a Chinese population. Int J Oral Maxillofac Surg (2006) 1.91
Life expectancy of children with cerebral palsy. Pediatr Neurol (1998) 1.90
Cross-regulatory roles of interleukin (IL)-12 and IL-10 in atherosclerosis. J Clin Invest (1996) 1.79
Differential sensitivity of p53(-) and p53(+) cells to caffeine-induced radiosensitization and override of G2 delay. Cancer Res (1995) 1.77
Regulated overexpression of interleukin 11 in the lung. Use to dissociate development-dependent and -independent phenotypes. J Clin Invest (1997) 1.74
Optimizing timing of ventricular defibrillation. Crit Care Med (2001) 1.74
cDNA cloning of murine Nrf 2 gene, coding for a p45 NF-E2 related transcription factor. Biochem Biophys Res Commun (1995) 1.73
Peroxisome proliferator-activated receptor activators target human endothelial cells to inhibit leukocyte-endothelial cell interaction. Arterioscler Thromb Vasc Biol (1999) 1.72
Genetic analysis by peptide nucleic acid affinity MALDI-TOF mass spectrometry. Nat Biotechnol (1997) 1.71
A skeleton in the atherosclerosis closet. Circulation (1995) 1.69
Cytologic grading of invasive breast carcinoma. Correlation with clinicopathologic variables and predictive value of nodal metastasis. Acta Cytol (2000) 1.68
Does coronary artery screening by electron beam computed tomography motivate potentially beneficial lifestyle behaviors? Am J Cardiol (1996) 1.67
Rhinovirus stimulation of interleukin-6 in vivo and in vitro. Evidence for nuclear factor kappa B-dependent transcriptional activation. J Clin Invest (1996) 1.66
Genetic variation in F3 (tissue factor) and the risk of incident venous thrombosis: meta-analysis of eight studies. J Thromb Haemost (2012) 1.66
Matrix GLA protein modulates differentiation induced by bone morphogenetic protein-2 in C3H10T1/2 cells. J Biol Chem (2001) 1.64
Comparisons between sublingual and gastric tonometry during hemorrhagic shock. Chest (2000) 1.62
Prognostic value of coronary electron-beam computed tomography for coronary heart disease events in asymptomatic populations. Am J Cardiol (2000) 1.60
Minimally modified low density lipoprotein is biologically active in vivo in mice. J Clin Invest (1991) 1.57
Metabolic and functional recovery of ischemic human myocardium after coronary angioplasty. J Am Coll Cardiol (1991) 1.57
Atherogenic high-fat diet reduces bone mineralization in mice. J Bone Miner Res (2001) 1.55
p53-null cells are more sensitive to ultraviolet light only in the presence of caffeine. Cancer Res (1996) 1.54
Diacylglycerol kinase epsilon regulates seizure susceptibility and long-term potentiation through arachidonoyl- inositol lipid signaling. Proc Natl Acad Sci U S A (2001) 1.51
Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study. Diabet Med (2013) 1.51
Inactivation of p53 results in high rates of homologous recombination. Oncogene (1997) 1.51
Networking senescence-regulating pathways by using Arabidopsis enhancer trap lines. Plant Physiol (2001) 1.49
Coronary calcium: the good, the bad, and the uncertain. Am Heart J (1999) 1.49
Atherosclerotic calcification: relation to developmental osteogenesis. Am J Cardiol (1995) 1.48
Mandibular coronoid fractures: treatment options. Int J Oral Maxillofac Surg (2013) 1.48
A novel endonuclease mechanism directly visualized for I-PpoI. Nat Struct Biol (1999) 1.43
Prognostic significance of cardiac cinefluoroscopy for coronary calcific deposits in asymptomatic high risk subjects. J Am Coll Cardiol (1994) 1.42
cAMP stimulates osteoblast-like differentiation of calcifying vascular cells. Potential signaling pathway for vascular calcification. J Biol Chem (1998) 1.38
High-energy defibrillation increases the severity of postresuscitation myocardial dysfunction. Circulation (1997) 1.36
Offline assessment of atherosclerotic coronary calcium from electron beam tomograms. Am J Card Imaging (1995) 1.34
Molecular cloning and characterization of a novel human diacylglycerol kinase zeta. J Biol Chem (1996) 1.31
Exofacial epitope-tagged glucose transporter chimeras reveal COOH-terminal sequences governing cellular localization. J Cell Biol (1993) 1.30
Leptin enhances the calcification of vascular cells: artery wall as a target of leptin. Circ Res (2001) 1.28
Role of lipids in osteoporosis. Arterioscler Thromb Vasc Biol (2000) 1.24
Genetic determination of cartilaginous metaplasia in mouse aorta. Arterioscler Thromb Vasc Biol (1995) 1.24
Human rsk isoforms: cloning and characterization of tissue-specific expression. Am J Physiol (1994) 1.23
Atherogenic diet and minimally oxidized low density lipoprotein inhibit osteogenic and promote adipogenic differentiation of marrow stromal cells. J Bone Miner Res (1999) 1.21
Acupuncture mycobacteriosis. N Engl J Med (2001) 1.20
Passive biaxial mechanical properties of isolated canine myocardium. J Physiol (1983) 1.20
Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control. Oncogene (2000) 1.18
Uncorrected refractive error in Singapore teenagers. Br J Ophthalmol (2006) 1.17
N-3 fatty acids inhibit vascular calcification via the p38-mitogen-activated protein kinase and peroxisome proliferator-activated receptor-gamma pathways. Circ Res (2006) 1.17
A class of distribution-free models for longitudinal mediation analysis. Psychometrika (2013) 1.17
Lipid hypothesis of cardiovascular calcification. Circulation (1997) 1.15
Recent advances in multifactorial regulation of vascular calcification. Curr Opin Lipidol (2001) 1.15
Myocardial dysfunction after successful resuscitation from cardiac arrest. Crit Care Med (1996) 1.12
Racial differences in coronary calcium prevalence among high-risk adults. Am J Cardiol (1995) 1.12
Rhinovirus stimulation of interleukin-8 in vivo and in vitro: role of NF-kappaB. Am J Physiol (1997) 1.11
Inhibition of osteoblast-specific transcription factor Cbfa1 by the cAMP pathway in osteoblastic cells. Ubiquitin/proteasome-dependent regulation. J Biol Chem (1999) 1.11
Distribution-free models for longitudinal count responses with overdispersion and structural zeros. Stat Med (2012) 1.08
High frequency and error-prone DNA recombination in ataxia telangiectasia cell lines. J Biol Chem (1996) 1.08
Investigation of the immunosuppressive activity of artemether on T-cell activation and proliferation. Br J Pharmacol (2007) 1.08
Prospective study of sickle cell trait and venous thromboembolism incidence. J Thromb Haemost (2014) 1.08
Coronary calcium and atherosclerosis by ultrafast computed tomography in asymptomatic men and women: relation to age and risk factors. Am Heart J (1994) 1.06
Socio-economic factors affecting the success of tuberculosis treatment in six counties of Shandong Province, China. Int J Tuberc Lung Dis (2010) 1.06
Sublingual capnometry for diagnosis and quantitation of circulatory shock. Am J Respir Crit Care Med (1998) 1.06
Pulsatile flow regulates monocyte adhesion to oxidized lipid-induced endothelial cells. Arterioscler Thromb Vasc Biol (2001) 1.05
Hepatitis B virus X protein downregulates expression of the miR-16 family in malignant hepatocytes in vitro. Br J Cancer (2011) 1.05
Association of obesity and atrial fibrillation among middle-aged and elderly Chinese. Int J Obes (Lond) (2009) 1.05
Role of molecular regulation in vascular calcification. J Atheroscler Thromb (1996) 1.05
Regulatory mechanisms in vascular calcification. Crit Rev Eukaryot Gene Expr (2000) 1.04
Angiotensin II receptor subtypes are coupled with distinct signal-transduction mechanisms in neurons and astrocytes from rat brain. Proc Natl Acad Sci U S A (1991) 1.04
Somatodendritic localization of Translin, a component of the Translin/Trax RNA binding complex. J Neurochem (2000) 1.04
Decreases in organ blood flows associated with increases in sublingual PCO2 during hemorrhagic shock. J Appl Physiol (1985) (1998) 1.04
Prostate cancer genes associated with TMPRSS2-ERG gene fusion and prognostic of biochemical recurrence in multiple cohorts. Br J Cancer (2010) 1.03